Healthcare -
Biotechnology - NASDAQ - US
$ 3.5
-0.293 %
$ 670 M
Market Cap
-8.29
P/E
ABUS - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ABUS - Arbutus Biopharma Corporation
22.9 M
LAST VALUE
51.86%
2 YEAR CAGR
-4.13%
5 YEAR CAGR
9.74%
10 YEAR CAGR